½ÃÀ庸°í¼­
»óǰÄÚµå
1761765

¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

Enteric Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research»ç´Â ÃÖ±Ù ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå¿¡ °üÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. º» º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, ÃËÁø¿äÀÎ, °úÁ¦ µîÀÇ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ »ó¼¼ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼® º¸°í¼­´Â ¼¼°è Àå¿ë¼º °øÄ¸½¶ÀÇ 2025-2032³â ¿¹Ãø ¼ºÀå ±Ëµµ¸¦ °³·«ÀûÀ¸·Î ¼³¸íÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ ¹× Åë°è¸¦ °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • Àå¿ë¼º °øÄ¸½¶ ½ÃÀå ±Ô¸ð(2025³â) : 31¾ï ´Þ·¯
  • ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 46¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR, 2025-2032³â) : 6%

Àå¿ë¼º °øÄ¸½¶ ½ÃÀå : ºÐ¼® ¹üÀ§

Àå¿ë¼º °øÄ¸½¶Àº À§ÀÇ »ê¼º ȯ°æ¿¡¼­´Â ºØ±«µÇ±â ¾î·Æ°í ÀåÀÇ Áß¼º¿¡¼­ ¾ËÄ®¸®¼º ȯ°æ¿¡¼­¸¸ ¿ëÇØµÇµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Ä¸½¶µéÀº Àå°ü Èí¼ö ¶Ç´Â À§»êÀ¸·ÎºÎÅÍÀÇ º¸È£¸¦ ÇÊ¿ä·Î ÇÏ´Â °í°¨µµ ÀǾàǰ À¯È¿¼ººÐ(API)À» Àü´ÞÇϱâ À§ÇØ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Á¦¾à, ¿µ¾ç º¸Á¶ ½Äǰ, ¿¬±¸ÀÇ °¢ ºÐ¾ß¿¡ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ¾î Á©¶óƾ º£À̽º ¹× ÇÏÀ̵å·Ï½ÃÇÁ·ÎÇÊ¸ÞÆ¿¼¿·ê·Î½º(HPMC) º£À̽ºÀÇ ¾çÂÊ Ä¸½¶À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¾à¹° Àü´Þ¿¡ ´ëÇÑ ¼ö¿ä Áõ´ë, ȯÀÚ ÄÄÇöóÀ̾𽺠Çâ»ó, ¹ÙÀÌ¿À °¡¿ë¼º°ú ¾ÈÁ¤¼ºÀ» ³ôÀ̴ ĸ½¶ ½© ±â¼úÀÇ Áøº¸ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀåÀº »ê¿¡ ¹Î°¨ÇÑ ¿ø·áÀÇ ¾ÈÁ¤¼º°ú È¿´ÉÀ» ³ôÀÌ´Â °æ±¸ ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¿µ¾ç º¸Á¶ ½Äǰ ºÐ¾ß¿¡¼­´Â ½Ä¹° À¯·¡·Î Á©¶óƾÀ» Æ÷ÇÔÇÏÁö ¾Ê´Â ĸ½¶¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±âÈ£°¡ ³ô¾ÆÁö°í ÀÖ¾î HPMC ±â¹Ý Àå¿ë¼º °øÄ¸½¶ÀÇ µµÀÔÀ» ÁöÁöÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¸¸¼ºÁúȯ, ƯÈ÷ À§ÀåÀå¾Ö ±ÞÁõ ¹× ³ëÀÎ Àα¸ Áõ°¡°¡ È¿°úÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù. Æú¸®¸Ó ºí·»µå³ª ¾×ü ĸ½¶È­ ´É·ÂÀÇ Çâ»ó µî, ĸ½¶ Á¦Á¶¿¡¼­ ±â¼ú °³Ã´µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ ¼ºÀåÀÌ ¿¹»óµÇ´Â Àå¿ë¼º °øÄ¸½¶ ½ÃÀåÀº ³ôÀº Á¦Á¶ ºñ¿ë ¹× Àå¿ë¼º ÄÚÆÃ Àç·á¿Í °ü·ÃµÈ ±ÔÁ¦ÀÇ º¹À⼺°ú °ü·ÃµÈ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ĸ½¶Á¦Á¦ÀÇ ¾ö°ÝÇÑ °ËÁõ ¹× ½ÂÀÎ ÇÁ·Î¼¼½º´Â, Áß¼Ò±â¾÷¿¡¼­ Âü°¡ À庮ÀÌ µË´Ï´Ù. °Ô´Ù°¡ ƯÈ÷ Á©¶óƾÀ̳ª HPMC µîÀÇ ¿øÀç·á¿¡ À־ÀÇ °ø±Þ¸ÁÀÇ È¥¶õÀº, Á¦Á¶ ½ºÄÉÁÙ¿¡ ¿µÇâÀ» ÁÖ¾î ¿î¿ë ºñ¿ëÀ» Áõ°¡½Ãų °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Àå¿ë¼º °øÄ¸½¶ÀÇ ±â´ÉÀû ÀÌÁ¡¿¡ ´ëÇÑ ½ÅÈï ½ÃÀå ¼ÒºñÀÚµéÀÇ ³·Àº Àνĵµ ½ÃÀå ħÅõ¿¡ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

Àå¿ë¼º °øÄ¸½¶Àº ¸ÂÃãÇü ÀÇ·á ä¿ë Áõ°¡, ¼öŹÁ¦Á¶±â°ü(CMO)ÀÇ È®´ë, ¿µ¾çº¸Á¶½Äǰ¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. Á¤¹Ð ¾à¹° Ÿ°ÙÆÃ ¹× º¹ÇÕ ¾à¹° Àü´Þ ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ Ä¸½¶È­ ±â¼úÀÇ °³¹ßÀº ½ÅÁ¦Ç° °³¹ßÀÇ °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù. ´Ù¾çÇÑ Áö¿ª¿¡¼­ ºñ°ÇÀ̳ª ÇÒ¶ö ÀÎÁõÀ» ¹ÞÀº ĸ½¶À» ã´Â °æÇâÀÌ °­ÇØÁö°í ÀÖ¾î ½ÃÀå °ü°èÀÚ´Â ´Ù¾çÇÑ ¼ÒºñÀÚÀÇ ±âÈ£¿¡ ÀÀÇÏ´Â »õ·Î¿î ±âȸ¸¦ ¾ò°í ÀÖ½À´Ï´Ù. ÀǾàǰ ºê·£µå ¹× ¿µ¾ç º¸Á¶ ½Äǰ ºê·£µå¿ÍÀÇ Àü·«Àû Á¦ÈÞ´Â, »ýºÐÇØ¼ºÀ¸·Î Áö¼Ó °¡´ÉÇÑ Ä¸½¶ ¼ÒÀçÀÇ Çõ½Å°ú ÇÔ²², ÀÌ ÁøÈ­ÇÏ´Â ½ÃÀå ȯ°æ¿¡¼­ »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇϱâ À§Çؼ­ ºÒ°¡°áÇÕ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • Á¦¾à ¹× ¿µ¾çº¸Á¶½Äǰ ºÐ¾ß¿¡¼­ ä¿ëÀ» ÃËÁøÇϴ ĸ½¶ ¼ÒÀç ¹× ¿ëµµ´Â ¹«¾ùÀΰ¡?
  • ±â¼úÀÇ Áøº¸´Â Àå¿ë¼º °øÄ¸½¶ ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ¹Ù²Ù°í Àִ°¡?
  • Àå¿ë¼º °øÄ¸½¶ ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ¹«¾ùÀ̸ç, ½ÃÀåÀÇ °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è Àå¿ë¼º °øÄ¸½¶ ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ ¹× Àå·¡¼ºÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§ ¹× Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • Àå¿ë¼º °øÄ¸½¶ ½ÃÀå : ¹ë·ùüÀÎ
    • ÁÖ¿ä ±â¾÷ ¸ñ·Ï
    • ÁÖ¿ä ¸®¼¿·¯ ¸ñ·Ï
  • ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
  • COVID-19ÀÇ ¿µÇâ Æò°¡
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦3Àå ÁÖ¿ä ±ÔÁ¦ ¹× ±âÁØ

Á¦4Àå °¡°Ý µ¿Ç⠺м®(2019-2032³â)

  • °¡°ÝÀÇ ¿µÇâ¿äÀÎ
  • ¿ø·áº° °¡°Ý

Á¦5Àå ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

  • ½ÃÀå ±Ô¸ð ºÐ¼® ¹× ¿¹Ãø(±Ý¾× ±âÁØ)
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2025-2032³â)
  • ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : Á¦Ç° À¯Çüº°
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç° À¯Çüº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø : Á¦Ç° À¯Çüº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • Á©¶óƾ ĸ½¶
      • È÷µå·Ï½ÃÇÁ·ÎÆÄÀÏ¸ÞÆ¿¼¿·ê·Î¿À½º(HPMC) ĸ½¶
      • ¾ßä ĸ½¶
    • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
  • ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : ÃÖÁ¾ »ç¿ëÀÚº°
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • Á¦¾à Á¦Á¶¾÷ü
      • ¿µ¾ç º¸Á¶ ½Äǰ Á¦Á¶¾÷ü
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
  • ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : ¿ëµµº°
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø : ¿ëµµº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • Á¦»êÁ¦ ¹× Á¤ÀåÁ¦
      • Ç×»ýÁ¦ ¹× Ç×±ÕÁ¦
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : Áö¿ªº°

  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(±Ý¾× ±âÁØ, 2019-2024³â)
  • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ, 2025-2032³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦7Àå ºÏ¹ÌÀÇ Àå¿ë¼º °øÄ¸½¶ÀÇ Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦8Àå À¯·´ÀÇ Àå¿ë¼º °øÄ¸½¶ÀÇ Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦10Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ Àå¿ë¼º °øÄ¸½¶ Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Àå¿ë¼º °øÄ¸½¶ ½ÃÀå Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àå¿ë¼º °øÄ¸½¶ÀÇ Àü¸Á : °ú°Å(2019-2024³â) ¹× ¿¹Ãø(2025-2032³â)

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸Ê : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
    • °èÃþ ±¸Á¶ ºÐ¼®
    • Áö¿ª ÇÁ·¹Á𽺠ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Lonza
    • Roquette Freres
    • Suheung
    • Farmacapsulas
    • Nectar Lifesciences Ltd.
    • Zhejiang huili capsules co. Ltd.
    • Shaoxing zhongya capsule co., Ltd.
    • Chemcaps ltd.
    • Fortcaps
    • Natural capsules limited

Á¦14Àå ºÎ·Ï

  • ºÐ¼® ¹æ¹ý
  • ºÐ¼®ÀÇ ÀüÁ¦
  • µÎÀÚ¾î ¹× ¾à¾î
AJY 25.07.10

Persistence Market Research has recently released a comprehensive report on the worldwide market for enteric empty capsules. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global enteric empty capsules market from 2025 to 2032.

Key Insights:

  • Enteric Empty Capsules Market Size (2025E): USD 3.1 Billion
  • Projected Market Value (2032F): USD 4.6 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6%

Enteric Empty Capsules Market - Report Scope:

Enteric empty capsules are designed to resist disintegration in the stomach's acidic environment and dissolve only in the more neutral to alkaline environment of the intestine. These capsules are widely used to deliver sensitive active pharmaceutical ingredients (APIs) that require intestinal absorption or protection from gastric acid. The market serves the pharmaceutical, nutraceutical, and research sectors, offering both gelatin-based and hydroxypropyl methylcellulose (HPMC)-based capsules, with increasing focus on vegetarian and clean-label formulations. Market growth is driven by rising demand for targeted drug delivery, improved patient compliance, and advancements in capsule shell technology enhancing bioavailability and stability.

Market Growth Drivers:

The global enteric empty capsules market is propelled by several key factors, including the increasing demand for oral drug delivery systems that enhance the stability and efficacy of acid-sensitive APIs. Growing consumer preference for plant-based and gelatin-free capsules, especially in the nutraceuticals sector, supports the uptake of HPMC-based enteric capsules. Additionally, the surge in chronic disease prevalence, particularly gastrointestinal disorders, and the expanding geriatric population boost demand for effective and patient-friendly dosage forms. Technological developments in capsule manufacturing, such as improved polymer blends and liquid encapsulation capabilities, also contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the enteric empty capsules market faces challenges related to high manufacturing costs and regulatory complexities associated with enteric coating materials. The stringent validation and approval processes for new capsule formulations pose entry barriers for small and medium-sized enterprises. Furthermore, supply chain disruptions, particularly in raw materials such as gelatin and HPMC, can impact production timelines and increase operational costs. Limited awareness among emerging market consumers about the functional benefits of enteric capsules also hinders wider market penetration.

Market Opportunities:

The enteric empty capsules market presents significant growth opportunities driven by the increasing adoption of personalized medicine, expansion of contract manufacturing organizations (CMOs), and rising investments in nutraceuticals. Advances in encapsulation technologies, including precision drug targeting and combination drug delivery systems, offer potential for new product development. The growing trend toward vegan and halal-certified capsules in various regions creates new opportunities for market players to cater to diverse consumer preferences. Strategic collaborations with pharmaceutical and nutraceutical brands, along with innovation in biodegradable and sustainable capsule materials, are vital to capturing emerging opportunities in this evolving market landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the enteric empty capsules market globally?
  • Which capsule materials and applications are driving adoption across pharmaceutical and nutraceutical sectors?
  • How are technological advancements reshaping the competitive landscape of the enteric empty capsules market?
  • Who are the key players contributing to the enteric capsules market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global enteric empty capsules market?

Competitive Intelligence and Business Strategy:

Leading players in the global enteric empty capsules market, including Capsugel (Lonza Group), Qualicaps, ACG Worldwide, and Suheung Co., Ltd., focus on innovation, regulatory compliance, and sustainable practices to maintain market leadership. These companies are investing in research and development to create capsules with enhanced disintegration control, compatibility with sensitive APIs, and alignment with clean-label trends. Strategic alliances with pharmaceutical companies and increased capacity expansion across emerging markets strengthen their global footprint. Emphasis on quality assurance, regulatory certifications, and product differentiation ensures sustained competitiveness in this dynamic industry.

Key Companies Profiled:

  • Lonza
  • Roquette Freres
  • SUHEUNG
  • Farmacapsulas
  • Nectar Lifesciences Ltd.
  • ZHEJIANG HUILI CAPSULES CO., LTD;
  • Shaoxing Zhongya Capsule Co., Ltd.;
  • Chemcaps Limited;
  • Fortcaps;
  • Natural Capsules Limited

Enteric Empty Capsules Market Research Segmentation:

The enteric empty capsules market encompasses a diverse range of materials, applications, and end-user segments, supporting targeted drug delivery and enhanced patient outcomes.

By Product

  • Gelatin Capsules
  • Hydroxypropyl Methylcellulose (HPMC) Capsules
  • Vegetable Capsules

By End-user

  • Pharmaceutical Manufacturers
  • Nutraceutical Manufacturers
  • Others

By Application

  • Antacid and Antiflatulent Preparations
  • Antibiotic and Antibacterial Drugs
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Enteric Empty Capsules Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Industry Developments and Key Market Events
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Enteric Empty Capsules Market: Value Chain
    • 2.3.1. List of key players
    • 2.3.2. List of key distributors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. Covid-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Factors Impacting Prices
  • 4.2. Prices by Source

5. Global Enteric Empty Capsules Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Market Size (US$ Bn) Analysis and Forecast
    • 5.1.1. Historical Market Size Analysis, 2019-2024
    • 5.1.2. Current Market Size Forecast, 2025-2032
  • 5.2. Global Enteric Empty Capsules Market Outlook: Product
    • 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2025-2032
      • 5.2.2.1. Gelatin Capsules
      • 5.2.2.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
      • 5.2.2.3. Vegetable capsules
    • 5.2.3. Market Attractiveness Analysis: Product
  • 5.3. Global Enteric Empty Capsules Market Outlook: End-user
    • 5.3.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2024
    • 5.3.2. Current Market Size (US$ Bn) Forecast By End-user, 2025-2032
      • 5.3.2.1. Pharmaceutical Manufacturers
      • 5.3.2.2. Nutraceutical Manufacturers
      • 5.3.2.3. Others
    • 5.3.3. Market Attractiveness Analysis: End-user
  • 5.4. Global Enteric Empty Capsules Market Outlook: Application
    • 5.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2024
    • 5.4.2. Current Market Size (US$ Bn) Forecast By Application, 2025-2032
      • 5.4.2.1. Antacid & Antiflatulent Preparations
      • 5.4.2.2. Antibiotic and Antibacterial Drugs
      • 5.4.2.3. Others
    • 5.4.3. Market Attractiveness Analysis: Application

6. Global Enteric Empty Capsules Market Outlook: Region

  • 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2024
  • 6.2. Current Market Size (US$ Bn) Forecast By Region, 2025-2032
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. East Asia
    • 6.2.4. South Asia and Oceania
    • 6.2.5. Latin America
    • 6.2.6. Middle East & Africa
  • 6.3. Market Attractiveness Analysis: Region

7. North America Enteric Empty Capsules Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Product
    • 7.1.3. By Application
    • 7.1.4. By End-user
  • 7.2. Current Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. North America Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 7.3.1. Gelatin Capsules
    • 7.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 7.3.3. Vegetable capsules
  • 7.4. North America Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 7.4.1. Pharmaceutical Manufacturers
    • 7.4.2. Nutraceutical Manufacturers
    • 7.4.3. Others
  • 7.5. North America Current Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 7.5.1. Antacid & Antiflatulent Preparations
    • 7.5.2. Antibiotic and Antibacterial Drugs
    • 7.5.3. Others
  • 7.6. Market Attractiveness Analysis

8. Europe Enteric Empty Capsules Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Product
    • 8.1.3. By End-user
    • 8.1.4. By Application
  • 8.2. Current Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
  • 8.3. Europe Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 8.3.1. Gelatin Capsules
    • 8.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 8.3.3. Vegetable capsules
  • 8.4. Europe Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 8.4.1. Pharmaceutical Manufacturers
    • 8.4.2. Nutraceutical Manufacturers
    • 8.4.3. Others
  • 8.5. Europe Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 8.5.1. Antacid & Antiflatulent Preparations
    • 8.5.2. Antibiotic and Antibacterial Drugs
    • 8.5.3. Others

9. East Asia Enteric Empty Capsules Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Product
    • 9.1.3. By Application
    • 9.1.4. By End-user
  • 9.2. East Asia Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 9.2.1. China
    • 9.2.2. Japan
    • 9.2.3. South Korea
  • 9.3. East Asia Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 9.3.1. Gelatin Capsules
    • 9.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 9.3.3. Vegetable capsules
  • 9.4. East Asia Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 9.4.1. Pharmaceutical Manufacturers
    • 9.4.2. Nutraceutical Manufacturers
    • 9.4.3. Others
  • 9.5. East Asia Current Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 9.5.1. Antacid & Antiflatulent Preparations
    • 9.5.2. Antibiotic and Antibacterial Drugs
    • 9.5.3. Others
  • 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Enteric Empty Capsules Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Product
    • 10.1.3. By End-user
    • 10.1.4. By Application
  • 10.2. Current Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 10.2.1. India
    • 10.2.2. Southeast Asia
    • 10.2.3. ANZ
    • 10.2.4. Rest of South Asia & Oceania
  • 10.3. South Asia & Oceania Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 10.3.1. Gelatin Capsules
    • 10.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 10.3.3. Vegetable capsules
  • 10.4. South Asia & Oceania Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 10.4.1. Pharmaceutical Manufacturers
    • 10.4.2. Nutraceutical Manufacturers
    • 10.4.3. Others
  • 10.5. South Asia & Oceania Current Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 10.5.1. Antacid & Antiflatulent Preparations
    • 10.5.2. Antibiotic and Antibacterial Drugs
    • 10.5.3. Others
  • 10.6. Market Attractiveness Analysis

11. Latin America Enteric Empty Capsules Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Product
    • 11.1.3. By End-user
    • 11.1.4. By Application
  • 11.2. Latin America Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 11.2.1. Brazil
    • 11.2.2. Mexico
  • 11.3. Latin America Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 11.3.1. Gelatin Capsules
    • 11.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 11.3.3. Vegetable capsules
  • 11.4. Latin America Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 11.4.1. Pharmaceutical Manufacturers
    • 11.4.2. Nutraceutical Manufacturers
    • 11.4.3. Others
  • 11.5. Latin America Current Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 11.5.1. Antacid & Antiflatulent Preparations
    • 11.5.2. Antibiotic and Antibacterial Drugs
    • 11.5.3. Others
  • 11.6. Market Attractiveness Analysis

12. Middle East & Africa Enteric Empty Capsules Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2024
    • 12.1.1. By Country
    • 12.1.2. By Product
    • 12.1.3. By End-user
    • 12.1.4. By Application
  • 12.2. Current Market Size (US$ Bn) Forecast By Country, 2025-2032
    • 12.2.1. GCC
    • 12.2.2. South Africa
    • 12.2.3. Northern Africa
  • 12.3. Middle East & Africa Market Size (US$ Bn) Forecast By Product, 2025-2032
    • 12.3.1. Gelatin Capsules
    • 12.3.2. Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 12.3.3. Vegetable capsules
  • 12.4. Middle East & Africa Market Size (US$ Bn) Forecast By End-user, 2025-2032
    • 12.4.1. Pharmaceutical Manufacturers
    • 12.4.2. Nutraceutical Manufacturers
    • 12.4.3. Others
  • 12.5. Middle East & Africa Market Size (US$ Bn) Forecast By Application, 2025-2032
    • 12.5.1. Antacid & Antiflatulent Preparations
    • 12.5.2. Antibiotic and Antibacterial Drugs
    • 12.5.3. Others
  • 12.6. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
    • 13.2.3. Tier Structure Analysis
    • 13.2.4. Regional Presence Analysis
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Lonza
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Roquette Freres
    • 13.3.3. Suheung
    • 13.3.4. Farmacapsulas
    • 13.3.5. Nectar Lifesciences Ltd.
    • 13.3.6. Zhejiang huili capsules co. Ltd.
    • 13.3.7. Shaoxing zhongya capsule co., Ltd.
    • 13.3.8. Chemcaps ltd.
    • 13.3.9. Fortcaps
    • 13.3.10. Natural capsules limited

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦